Berkeley Lights Operating Expenses 2011-2026 | BLI

Annual Operating Expenses Berkeley Lights

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
152 M	127 M	84.9 M	60 M	44.3 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
152 M	44.3 M	93.7 M

Quarterly Operating Expenses Berkeley Lights

2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
53.2 M	36.3 M	-	36.6 M	38.5 M	35.1 M	-	35.4 M	30.6 M	27.6 M	-	21 M	19.1 M	18.2 M	-	15.9 M	15.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
53.2 M	15.2 M	29.4 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Allakos ALLK	196 M	-	-	$ 28.6 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Alterity Therapeutics Limited ATHE	16.7 M	$ 4.58	-	$ 11 B	Australia
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
AlloVir ALVR	46.2 M	-	4.14 %	$ 49.1 M	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	20.7 M	$ 0.88	-	$ 6.47 M	China
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	708 M	$ 22.67	-	$ 3.76 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Applied Therapeutics APLT	74.5 M	-	-	$ 8.42 M	USA
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Galectin Therapeutics GALT	20.1 M	$ 2.32	-	$ 148 M	USA
Greenwich LifeSciences GLSI	16 M	$ 22.8	-	$ 297 M	USA
Genmab A/S GMAB	67.9 M	$ 26.79	-	$ 16.8 B	Danmark
Avenue Therapeutics ATXI	4.49 M	-	-52.27 %	$ 4.45 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Aeterna Zentaris AEZS	13.3 M	-	5.93 %	$ 314 M	Canada
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	23.4 K	-	17.91 %	$ 11.1 M	USA
Atreca BCEL	98.7 M	-	-11.76 %	$ 5.79 M	USA
BioNTech SE BNTX	512 M	$ 102.06	-	$ 27.2 B	Germany
Brainstorm Cell Therapeutics BCLI	31.7 M	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
Innoviva INVA	144 M	$ 23.69	-	$ 1.6 B	USA
Aquestive Therapeutics AQST	85.5 M	$ 4.09	-	$ 437 M	USA
Arcutis Biotherapeutics ARQT	137 M	$ 23.29	-	$ 2.96 B	USA
Jaguar Health JAGX	36 M	$ 0.24	-	$ 560 K	USA
KalVista Pharmaceuticals KALV	161 M	$ 19.24	-	$ 1.04 B	Britain
Autolus Therapeutics plc AUTL	145 M	$ 1.48	-	$ 394 M	Britain
Kamada Ltd. KMDA	69 K	$ 8.15	-	$ 260 M	Israel
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
Kazia Therapeutics Limited KZIA	8.82 M	$ 11.85	-	$ 1.57 B	Australia
AstraZeneca PLC AZN	17.6 B	-	-	$ 96.9 B	Britain
AVROBIO AVRO	71.7 M	-	1083.1 %	$ 745 M	USA
Can-Fite BioPharma Ltd. CANF	14 M	$ 2.91	-	$ 4.79 M	Israel
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Evogene Ltd. EVGN	13.8 M	$ 0.79	-0.65 %	$ 27.9 M	Israel